AMGN Related Hot FDA News

Aug 8, 2012 04:04 PM Amgen (AMGN) Ceases Ganitumab Phase 3 GAMMA; DMC Says Statistically Significant Improvement Unlikely

Dec 5, 2011 08:51 AM Affymax (AFFY) Shares Surge as FDA Says Peginesatide Works as Well as Amgen Products

Dec 14, 2010 07:16 AM Amgen (AMGN) Jumps 8 Precent On Positive Denosumab Survival Data

Dec 13, 2010 05:56 PM Amgen's (AMGN) Denosumab Improves Survival by 4.2 Months (AMGN)